Tectonic Therapeutic, Inc. (TECX)

Tectonic Therapeutic, Inc. (TECX) is a healthcare company (biotechnology) based in the United States. The share price is $20.05, down 4.43% on the day, which values the company at $391.96M. Price as of 17 Nov 2026, 20:44 UTC, from Yahoo Finance.

Key facts

Share price
$20.05−4.43% today
Market value
$391.96M
200-week average
$22.2910% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Tectonic Therapeutic, Inc. in more detail

TECX trades at -4.2× next year's expected earnings. It sits 10% below its 200-week average of $22.29.

In its favour: More cash than debt. Worth checking: Thin interest cover.

1 of the superinvestors tracked here hold TECX, including Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding TECX

1 of the investors tracked here report a position in their latest 13F filing.

Tectonic Therapeutic, Inc. (TECX): questions and answers

What is Tectonic Therapeutic, Inc.'s market cap?

Tectonic Therapeutic, Inc. is valued at $391.96M at a share price of $20.05.

Is TECX above its 200-week moving average?

No. TECX is 10.0% below its 200-week average of $22.29. Long-term investors watch that line because strong companies rarely trade below it for long.

Does TECX pay a dividend?

Tectonic Therapeutic, Inc. does not currently pay a regular dividend.

Which famous investors own TECX?

In their latest quarterly filings, Julian and Felix Baker (0.1% of the portfolio) hold TECX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Tectonic Therapeutic, Inc. (TECX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TECX

Underlying data: Yahoo Finance; company filings with the SEC.